circRNA basic information
circBase ID: hsa_circ_0134036
Name: hsa_circ_TAX1BP1
Synonym: circTAX1BP1
Host Gene: TAX1BP1
Genomic location(hg19): -
Genomic location(hg38): -
Subcellular localization: extracellular vesicle
 
 
 
 
 
 
 
Disease basic information
MONDO ID:
0005575
MONDO name: colorectal cancer
Disease details: colorectal cancer / CRC
Disease DO ID:
5672, 9256
Disease MeSH ID:
-
Disease NCIt ID:
C4978
Disease ICD11 ID:
-
Disease OMIM ID:
114500
Species: Human
Species details: Homo sapiens
Tissue specimen:

normal adjacent tissues (NAT); primary colorectal tumor (PT) tissues; liver metastatic (LM) tissues; CRC tissues; plasma EVs

Cell lines:

HCT116; DLD1

In vivo animal model:

cell line-derived xenograft; patient-derived xenograft

circRNA-disease information
Expression pattern:
UP
Associated gene: VIRMA, AARS2, SP1, TGF-beta, Smad3
Associated microRNA: -
Biological function: promotes proliferation; promotes migration; promotes invasion; promotes liver metastasis; promotes tumor growth; promotes EMT
Molecular mechanism: EV-delivered circTAX1BP1 binds VIRMA and recruits AARS2 to promote VIRMA K1713 lactylation, increasing VIRMA-dependent m6A modification/stability of SP1 mRNA; SP1 enhances TGF-beta transcription to activate TGF-beta/SMAD signaling and EMT, forming a positive feedback loop with ITGA11+ myCAFs (via Smad3-driven circTAX1BP1 transcription).
Biological pathway or process:

m6A modification (promotes); mRNA stability (promotes); TGF-beta/SMAD (promotes); EMT (promotes); proliferation (promotes); migration (promotes); invasion (promotes); metastasis (promotes); other pathway/process (promotes)

Detected method:
Q
S
Validation methods:

RNA-seq; RT-qPCR; Back-Splice Junction PCR / divergent primers PCR; Sanger Sequencing; RNase R Treatment; Actinomycin D / DRB Stability Assay; FISH / smFISH; Nuclear-Cytoplasmic Fractionation; Clinical Sample Validation; Survival Analysis; RNA Pull-Down; RIP (RNA Immunoprecipitation); Luciferase Reporter Assay; ChIP / ChIP-seq; Transfection; CCK8; Colony Formation Assay; Transwell Assay; Wound Healing Assay; In Vivo Animal Model; IHC (Immunohistochemistry); H&E Staining; Bioinformatics Analysis; MeRIP / MeRIP-seq; Western Blot

Clinical significance:

High circTAX1BP1 expression is associated with liver metastasis and poorer OS/DFS in CRC; plasma EV circTAX1BP1 is upregulated in CRC and higher in LM-positive patients and shows diagnostic value (AUC 0.864).

Description:

CAF/ITGA11+ myCAF-derived EV circTAX1BP1 is up-regulated in CRC/CRLM and promotes tumor growth and liver metastasis. It acts mainly by binding VIRMA and recruiting AARS2 to enhance VIRMA K1713 lactylation, which increases VIRMA-dependent m6A modification and stability of SP1 mRNA, activating SP1→TGF-beta transcription, TGF-beta/SMAD signaling, and EMT, forming a positive feedback loop in the TME. Clinically, high circTAX1BP1 indicates poor OS/DFS and plasma EV circTAX1BP1 shows diagnostic potential.

Confidence score:

0.8988

Other information
Title:

Extracellular Vesicle-Packaged circTAX1BP1 from Cancer-Associated Fibroblasts Regulates RNA m6A Modification through Lactylation of VIRMA in Colorectal Cancer Cells.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: 2025
PubMed ID: 41017455
Study type:

combined biological and clinical study

Data availability: The data that support the findings of this study are available from the corresponding author upon reasonable request.
Code availability: -